• Two bowls overflowing with cheetos and doritos, plus a pile of potato chips on the table in front of the bowls.
    Choice of chips or an orange tests the munchies
    4/24/19

    As efforts to legalize cannabis grow, the need arises for tailored health education, authors of a UB-led study say.

  • Pen resting on a survey that uses the ideal number of response options.
    Strongly agree: Number of response options matters
    4/23/19

    UB psychologist Leonard Simms' research suggests that a response format should be given as much thought as the test itself.

  • Three opioids pain reliever pills on a flat surface in front of a prescription bottle tipped on it's side.
    Combating the opioid crisis
    4/18/19

    UB will host nearly 100 Fulbright Foreign Students later this month for an enrichment seminar on opioid crisis education.

  • Concept of clergy privilege: a priest with tape over his mouth stands in front of a building with the word "courts" on the side.
    Clergy privilege study shapes bill
    4/18/19

    Christine Pedigo Bartholomew's study marks first time a legal scholar examined and recorded every opinion on clergy privilege.

  • An "impossible burger" on a lilac background with a small flag sticking into the top bun that says "impossible.".
    Making sense of the Impossible Burger
    4/18/19

    Molecular biologist Mark O'Brian explains what's in the trendy veggie burger and what makes it look — and taste — like beef.

  • A structural module with a unique interlocked configuration that is easily assembled by a single worker.
    Innovation in steel assembly wins prize
    4/15/19

    UB architect Jin Young Song has advanced in a two-stage competition organized by the Association of Collegiate Schools of Architecture.
     

  • Two scientists in the lab examining a vial holding a yellowish solution.
    DC startup showcase invites UB company
    4/15/19

    Co-founded by a UB chemist, Ferric Contrast is developing new contrast agents for MRI diagnostics.

  • A scientist removes a long rectangular container from a nitrogen freezer, with white mist emerging from the freezer.
    Turning a patient's cells into cancer fighters
    4/10/19

    Tactiva Therapeutics, an immuno-oncology company and UB partner, is poised for growth in 2019.

  • Yellow dapaglifozin pills.
    UB research aids drug approval
    4/10/19

    Commission cited trial led by Paresh Dandona in announcing approval for dapagliflozin to treat Type 1 diabetes.

  • Oral contraceptive pills on a wooden background.
    Protecting against ovarian cancer
    4/9/19

    Study is the first to investigate the association between oral contraceptive use and risk of highly fatal ovarian cancer.

Next> <Previous